At @weeks , more patients in the liraglutide compared with the sulphonylurea group achieved a composite endpoint of haemoglobin A@c ( HbA@c ) < @ % , no weight gain and no severe hypoglycaemia but this did not reach statistical significance -LSB- odds ratio ( OR ) @ , @ % confidence interval ( CI ) @ , @ , p = @ -RSB- .